Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook

Stock Information for Bone Biologics Corp

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Bone Biologics Corp

Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook
Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference
Bone Biologics Announces Closing of $5.0 Million Public Offering
Bone Biologics Announces Pricing of $5.0 Million Public Offering
Bone Biologics Files Patent Application for Bone Regeneration Technology
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
Bone Biologics Announces 1-for-6 Reverse Stock Split

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.